ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "cyclophosphamide and outcomes"

  • Abstract Number: 2747 • 2017 ACR/ARHP Annual Meeting

    Long Term Follow-up of Behcet’s Syndrome Patients Treated with Cyclophosphamide

    Mert Gurcan1, Sinem Nihal Esatoglu1, Vedat Hamuryudan1, Caner Saygin2, Didem Saygin3, Serdal Ugurlu4, Emire Seyahi1, Melike Melikoglu1, Izzet Fresko1, Sebahattin Yurdakul1, Hasan Yazici1 and Gulen Hatemi1, 1Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 2Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Cleveland, OH, 3Internal Medicine, Department of Internal Medicine, Cleveland Clinic, Cleveland, Cleveland, OH, 4Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey

     Background/Purpose: Cyclophosphamide (CYC) remains an important treatment option for Behçet’s syndrome (BS) pts with life threatening conditions such as arterial aneurysms. However, several adverse events…
  • Abstract Number: 2645 • 2014 ACR/ARHP Annual Meeting

    Long-Term Efficacy and Safety of Pulse Cyclophosphamide for Neuropsychiatric Systemic Lupus Erythematosus: A Two-Centre Experience

    Antonis Fanouriakis1, Cristina Pamfil2, Laura O. Damian3, Ioana Felea3, Emmanuel Mihali4, Ileana Filipescu2, Theofanis Karageorgas5, Prodromos Sidiropoulos6, Simona Rednic2, George Bertsias6,7 and Dimitrios Boumpas5,7,8, 1Rheumatology, Clinical Immunology and Allergy, University of Crete, Heraklion, Greece, 2Rheumatology, University of Medicine and Pharmacy, Cluj-Napoca, Romania, 3Rheumatology, Emergency Clinical County Hospital Cluj, Cluj-Napoca, Romania, 4Emergency Clinical County Hospital Cluj, Cluj-Napoca, Romania, 5Clinical Immunology and Rheumatology, "Attikon" University Hospital of Athens, Athens, Greece, 6Rheumatology, Clinical Immunology, and Allergy, University of Crete, Heraklion, Greece, 7Institute of Molecular Biology and Biotechnology, Foundation of Research and Technology-Hellas, Heraklion, Crete, Greece, 8Biomedical Research Foundation, Academy of Athens, Athens, Greece

    Background/Purpose Cyclophosphamide (CYC) is often used in severe neuropsychiatric systemic lupus erythematosus. However, data on its use rely on small case series and a single…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies